SG Americas Securities’s Outlook Therapeutics OTLK Stock Holding History

SG Americas Securities’s Portfolio OTLK Stock Details OTLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27K	Buy	+17,271	New	+$10.7K	﹤0.01%	3246
2024 Q1	–	Sell	-1,876	Closed	-$15K	–	3307
2023 Q4	$15K	Buy	1,876 +876	+88%	+$7.41K	﹤0.01%	3021
2023 Q3	$4K	Buy	+1,000	New	+$22.1K	﹤0.01%	3074
2023 Q2	–	Sell	-3,097	Closed	-$68K	–	2939
2023 Q1	$68K	Buy	+3,097	New	+$69.3K	﹤0.01%	3016
2022 Q4	–	Sell	-1,246	Closed	-$30K	–	3299
2022 Q3	$30K	Buy	1,246 +361	+41%	+$8.39K	﹤0.01%	3061
2022 Q2	$18K	Buy	+885	New	+$25.4K	﹤0.01%	3345
2022 Q1	–	Sell	-1,262	Closed	-$34K	–	3316
2021 Q4	$34K	Sell	1,262 -979	-44%	-$34.9K	﹤0.01%	3225
2021 Q3	$97K	Buy	+2,241	New	+$108K	﹤0.01%	3671

Other funds holding OTLK

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GWM

Gilpin Wealth Management Denver, Colorado $145M AUM

SG Americas Securities's OTLK Position: Q2 2026 in Review

SG Americas Securities opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 17,271 shares worth $27K. The stake represents ﹤0.01% of the portfolio and ranks #3246 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in OTLK as recently as Q4 2023.

SG Americas Securities first reported a position in OTLK in Q3 2021 and has held it in 8 quarters since. The position peaked at $97K in Q3 2021. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

SG Americas Securities held 17,271 shares of Outlook Therapeutics worth $27K as of Q2 2026.
Outlook Therapeutics was a new SG Americas Securities position in Q2 2026.
Outlook Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3246 holding.
SG Americas Securities first reported a position in Outlook Therapeutics in Q3 2021 and has held it in 8 quarters since.
SG Americas Securities's Outlook Therapeutics position peaked at $97K in Q3 2021.
69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.